Fusion event
HBV-CTXND2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Region type
X protein|Polymerase|
Integrated sequence
CTGCCGTTCCGACCGACCACGGGGCGCACCTCTCTTTACGCGGACTCCCCGTCTGTGCCTTCTCATCTGCCGGACCGTGTGCACTTCGCTTCACCTCTGC| |ACGTCGCATGGAGACCACCGTGAACGCCCACCAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAG
End
150871613/150899137 (Hg38)
Nearest miRNA
hsa-mir-101-1/Upstream/347123; hsa-mir-1182/Downstream/646659;
Upstream sequence
cagtgagctgagatcacgccactgcactccagcctgggcgacagagcaagactccgtctcaaataaataaataaataaataaataaataaataaacaaac
Downstream sequence
aaacaaTAATAAACTCAAAAAGTccaagcatggtggctcacgcctgtaatcccagtgccttgggagggctaggtgagaggatcacttgaggccagaactt
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.